Cutera stock, medical devices

Cutera stock trades OTC after Nasdaq delisting

Published on 09/29/2026 at 15:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cutera held USD 19.85 million in short-term investments on September 21, 2026, down 19.63 percent year over year. Historical revenue fell to USD 138.5 million in 2024.

Cutera stock,  medical devices,  OTC Markets,  bankruptcy restructuring,  aesthetic laser technology, Illustration mit AI erstellt.
Cutera stock, medical devices, OTC Markets, bankruptcy restructuring, aesthetic laser technology, Illustration mit AI erstellt.

Cutera stock trades on OTC Markets under ticker CUTRQ after the company left Nasdaq during its 2025 restructuring. The latest dated balance-sheet figure shows USD 19.85 million in short-term investments on September 21, 2026, down 19.63 percent from USD 24.70 million in the prior year, according to Eulerpool.

OTC listing follows restructuring

Investing.com identifies Cutera as an OTC Markets company trading under CUTRQ and assigns the security the business identifier US2321091082. The company filed Chapter 11 on March 5, 2025, after reporting more than USD 429 million in debt, as AInvest reported on September 10, 2026.

The restructuring changed the investment case from a listed growth story to a distressed OTC security. AInvest reported that Cutera emerged from Chapter 11 in May 2025 after a debt exchange, while the company moved away from its former Nasdaq status.

Revenue decline explains the pressure

Cutera's historical revenue fell from USD 212.4 million in fiscal year 2023 to USD 138.5 million in fiscal year 2024, a decline of 34.82 percent, according to AInvest's September 10, 2026 account. The comparison matters because the restructuring followed a sharp contraction in the operating base rather than a normal period of slower growth.

Cutera's former Japanese distribution of ZO skincare products also contracted. Yahoo Finance reported that the business generated USD 34.0 million in 2023, compared with USD 42.5 million in 2022, with the two figures representing 16 percent and 17 percent of Cutera's total revenue.

Medical laser portfolio remains central

Cutera develops aesthetic and medical laser systems for skin rejuvenation, body contouring, hair removal, vascular lesions, scars and tattoo removal. Eulerpool describes a portfolio of more than 20 products, including Laser Genesis Plus, Excel HR, Sculpture and TruSculpt 3D.

Cutera stock stays OTC

Cutera stock has an OTC Markets listing under CUTRQ, while the company profile identifies the industry as Health Care Equipment and Supplies. The September 21, 2026 short-term investment figure of USD 19.85 million and its 19.63 percent year-over-year decline provide the clearest dated financial checkpoint for the restructured business.

Cutera stock facts

  • Company: Cutera, Inc.
  • Ticker: CUTRQ
  • Primary exchange: OTC Markets
  • Sector / Industry: Health Care Equipment and Supplies
  • Short-term investments: USD 19.85 million as of September 21, 2026

Disclaimer...

en | boerse | 70198791 |